Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in China / NCT04477967
Recruiting Observational

Design and Implementation of the Pediatric Liver Transplantation Biobank

NCT04477967 · tracked via the Priya Life Science China tracker
Sponsor
Children's Hospital of Chongqing Medical University
Phase
Observational
Started
2018-10-01
Last updated
2020-07-20

Condition(s) studied

Liver DiseasesLiver Transplant; ComplicationsPediatric ALL

Investigational drug(s) / intervention(s)

No intervention

No intervention: There are no interventions because it is a protocol study

Study summary

The purpose of the pediatric liver transplant biobank is to systematically collect clinical specimens from pediatric end-stage liver disease. It is expected to contribute to the research and development of paediatric end-stage liver disease in the future.

Eligibility

Sex
ALL
Min age
1 Month
Max age
18 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Children diagnosed with end-stage liver disease. 2. Liver transplantation in our hospital. 3. informed patient consent. 4. long-term follow-up in our hospital. Exclusion Criteria: No fixed contact information, difficult to follow up the patients.

Primary outcome measure(s)

  • Biological sample bank — 2 years
    A repository of biological samples from patients who will join the project, will be organised at the biobank center of the Children's Hospital of Chongqing Medical University(CHCMU) under the responsibility of the experienced staff at the Department of Hepatic.
  • Integrated health data platform — 2 years
    Collect patient clinical test information and establish diagnostic database.

Trial sites (1)

FacilityCityRegionStatus
Children's Hospital of Chongqing Medical University Chongqing Chongqing Municipality Recruiting

More Children's Hospital of Chongqing Medical University trials in China

The Role of Biomarkers in the Occurrence and Development of Asthma Recruiting
the Effect of High Caloric Oral Nutritional Supplements on Growth and Development of Malnourished Children Recruiting
Hepatitis B Vaccination After Neonatal Surgery Recruiting
The Clinical Application Study of Obinutuzumab in Pediatric Refractory Nephrotic Syndrome Active, not recruiting
Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet Recruiting

Other trials for the same condition

Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation Starting soon
The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine Recruiting
CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection Recruiting
A Study About Remote and Local Liver Surgery Starting soon
Efficacy and Safety of Immunosuppressive Withdrawal After Pediatric Liver Transplantation Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04477967 on ClinicalTrials.gov ↗ ← All trials in China